Cargando…

Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review

INTRODUCTION: Artificial intelligence based on machine learning has made large advancements in many fields of science and medicine but its impact on pharmacovigilance is yet unclear. OBJECTIVE: The present study conducted a scoping review of the use of artificial intelligence based on machine learni...

Descripción completa

Detalles Bibliográficos
Autores principales: Kompa, Benjamin, Hakim, Joe B., Palepu, Anil, Kompa, Kathryn Grace, Smith, Michael, Bain, Paul A., Woloszynek, Stephen, Painter, Jeffery L., Bate, Andrew, Beam, Andrew L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883349/
https://www.ncbi.nlm.nih.gov/pubmed/35579812
http://dx.doi.org/10.1007/s40264-022-01176-1
_version_ 1784879490134966272
author Kompa, Benjamin
Hakim, Joe B.
Palepu, Anil
Kompa, Kathryn Grace
Smith, Michael
Bain, Paul A.
Woloszynek, Stephen
Painter, Jeffery L.
Bate, Andrew
Beam, Andrew L.
author_facet Kompa, Benjamin
Hakim, Joe B.
Palepu, Anil
Kompa, Kathryn Grace
Smith, Michael
Bain, Paul A.
Woloszynek, Stephen
Painter, Jeffery L.
Bate, Andrew
Beam, Andrew L.
author_sort Kompa, Benjamin
collection PubMed
description INTRODUCTION: Artificial intelligence based on machine learning has made large advancements in many fields of science and medicine but its impact on pharmacovigilance is yet unclear. OBJECTIVE: The present study conducted a scoping review of the use of artificial intelligence based on machine learning to understand how it is used for pharmacovigilance tasks, characterize differences with other fields, and identify opportunities to improve pharmacovigilance through the use of machine learning. DESIGN: The PubMed, Embase, Web of Science, and IEEE Xplore databases were searched to identify articles pertaining to the use of machine learning in pharmacovigilance published from the year 2000 to September 2021. After manual screening of 7744 abstracts, a total of 393 papers met the inclusion criteria for further analysis. Extraction of key data on study design, data sources, sample size, and machine learning methodology was performed. Studies with the characteristics of good machine learning practice were defined and manual review focused on identifying studies that fulfilled these criteria and results that showed promise. RESULTS: The majority of studies (53%) were focused on detecting safety signals using traditional statistical methods. Of the studies that used more recent machine learning methods, 61% used off-the-shelf techniques with minor modifications. Temporal analysis revealed that newer methods such as deep learning have shown increased use in recent years. We found only 42 studies (10%) that reflect current best practices and trends in machine learning. In the subset of 154 papers that focused on data intake and ingestion, 30 (19%) were found to incorporate the same best practices. CONCLUSION: Advances from artificial intelligence have yet to fully penetrate pharmacovigilance, although recent studies show signs that this may be changing. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40264-022-01176-1.
format Online
Article
Text
id pubmed-9883349
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-98833492023-01-29 Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review Kompa, Benjamin Hakim, Joe B. Palepu, Anil Kompa, Kathryn Grace Smith, Michael Bain, Paul A. Woloszynek, Stephen Painter, Jeffery L. Bate, Andrew Beam, Andrew L. Drug Saf Review Article INTRODUCTION: Artificial intelligence based on machine learning has made large advancements in many fields of science and medicine but its impact on pharmacovigilance is yet unclear. OBJECTIVE: The present study conducted a scoping review of the use of artificial intelligence based on machine learning to understand how it is used for pharmacovigilance tasks, characterize differences with other fields, and identify opportunities to improve pharmacovigilance through the use of machine learning. DESIGN: The PubMed, Embase, Web of Science, and IEEE Xplore databases were searched to identify articles pertaining to the use of machine learning in pharmacovigilance published from the year 2000 to September 2021. After manual screening of 7744 abstracts, a total of 393 papers met the inclusion criteria for further analysis. Extraction of key data on study design, data sources, sample size, and machine learning methodology was performed. Studies with the characteristics of good machine learning practice were defined and manual review focused on identifying studies that fulfilled these criteria and results that showed promise. RESULTS: The majority of studies (53%) were focused on detecting safety signals using traditional statistical methods. Of the studies that used more recent machine learning methods, 61% used off-the-shelf techniques with minor modifications. Temporal analysis revealed that newer methods such as deep learning have shown increased use in recent years. We found only 42 studies (10%) that reflect current best practices and trends in machine learning. In the subset of 154 papers that focused on data intake and ingestion, 30 (19%) were found to incorporate the same best practices. CONCLUSION: Advances from artificial intelligence have yet to fully penetrate pharmacovigilance, although recent studies show signs that this may be changing. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40264-022-01176-1. Springer International Publishing 2022-05-17 2022 /pmc/articles/PMC9883349/ /pubmed/35579812 http://dx.doi.org/10.1007/s40264-022-01176-1 Text en © The Author(s) 2022, corrected publication 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review Article
Kompa, Benjamin
Hakim, Joe B.
Palepu, Anil
Kompa, Kathryn Grace
Smith, Michael
Bain, Paul A.
Woloszynek, Stephen
Painter, Jeffery L.
Bate, Andrew
Beam, Andrew L.
Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review
title Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review
title_full Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review
title_fullStr Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review
title_full_unstemmed Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review
title_short Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review
title_sort artificial intelligence based on machine learning in pharmacovigilance: a scoping review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883349/
https://www.ncbi.nlm.nih.gov/pubmed/35579812
http://dx.doi.org/10.1007/s40264-022-01176-1
work_keys_str_mv AT kompabenjamin artificialintelligencebasedonmachinelearninginpharmacovigilanceascopingreview
AT hakimjoeb artificialintelligencebasedonmachinelearninginpharmacovigilanceascopingreview
AT palepuanil artificialintelligencebasedonmachinelearninginpharmacovigilanceascopingreview
AT kompakathryngrace artificialintelligencebasedonmachinelearninginpharmacovigilanceascopingreview
AT smithmichael artificialintelligencebasedonmachinelearninginpharmacovigilanceascopingreview
AT bainpaula artificialintelligencebasedonmachinelearninginpharmacovigilanceascopingreview
AT woloszynekstephen artificialintelligencebasedonmachinelearninginpharmacovigilanceascopingreview
AT painterjefferyl artificialintelligencebasedonmachinelearninginpharmacovigilanceascopingreview
AT bateandrew artificialintelligencebasedonmachinelearninginpharmacovigilanceascopingreview
AT beamandrewl artificialintelligencebasedonmachinelearninginpharmacovigilanceascopingreview